Form 13-F position report

PROTEOSTASIS THERAPEUTICS I

Reported by DEUTSCHE BANK AG

PTI CUSIP 74373B109 Manager CIK 0000948046

Reported 0 shares, down 9,864 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2019
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 15 Through Q3 2019

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for PROTEOSTASIS THERAPEUTICS I held by DEUTSCHE BANK AG.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

59 managers reported PROTEOSTASIS THERAPEUTICS I for Q3 2019.

Managers reporting PROTEOSTASIS THERAPEUTICS I in Q3 2019.
Manager Activity Shares Change % of reported 13F Reported value Tenure
NEA Management Company LLC Unchanged 5,556,778 0 0.39% $4,695,000 15 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 4,858,931 -218,702 < 0.01% $4,105,000 7 qtrs
GREAT POINT PARTNERS LLC Unchanged 3,500,000 0 0.27% $2,958,000 4 qtrs
BlackRock Inc Reduced 1,546,825 -24,374 < 0.01% $1,307,000 14 qtrs
VANGUARD GROUP INC Added 1,159,336 +104,071 < 0.01% $979,000 14 qtrs
MACQUARIE GROUP LTD Reduced 750,000 -2,319 < 0.01% $634,000 4 qtrs
HarbourVest Partners LLC Unchanged 440,627 0 0.15% $372,000 11 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 411,468 -5,708 < 0.01% $347,000 15 qtrs
Rock Springs Capital Management LP Unchanged 400,000 0 0.01% $338,000 15 qtrs
ACADIAN ASSET MANAGEMENT LLC Reduced 288,336 -84,988 < 0.01% $243,000 6 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2019
Filed
November 14, 2019
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.